万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://www.springer.com/journal/12020
3、投稿网址：https://www.editorialmanager.com/endo
4、官网邮箱：editor.endocrine@gmail.com（主编）
5、期刊刊期：月刊，一个月出版一期。
2021年4月29星期四
投稿须知
【官网信息】
Submission guidelines
Types of papers
Manuscript categories
1. Original article
This contribution should contain original controlled experimental data of basic and clinical research. The manuscript should be organized in the following sections: Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Figure Legends, Tables, Figures. Manuscripts should not exceed 4,000 words, 60 references, and 7 tables/figures
2. Review
This contribution is usually solicited by the Editors. If unsolicited, the authors are advised to contact the Editor-in-Chief (editor.endocrine@gmail.com) with an outline of the proposed review and CV of the authors.
This type of article does not have a strict limit in word and reference number although the editorial recommendation is that the article does not exceed 4000 words and 350 references.
3. Mini-Review
This contribution is also usually solicited by the Editors. If unsolicited, the authors are advised to contact the Editor-in-Chief (editor.endocrine@gmail.com) with an outline of the proposed review and CV of the authors.
This type of article has a word limit of 2000 and no more than 100 references.
4. New Horizons in
This contribution should be based on the outcomes of a scientific meeting and will be devoted to underline open issues as well as future basic and clinical research perspectives in an endocrine field. This type of article has a word limit of 2000 and no more than 50 references. Interested authors should contact directly the Editor-in-Chief (editor.endocrine@gmail.com) submitting the meeting scientific program and an outline of their work.
5. Meta-analysis
This contribution should be based on a rigorous methodological/statistical approach described in detail in the methods section applied to a relevant clinical or basic issue. This work could also be submitted to statistical revision. Word limit is 3000 with no more than 100 references.
6. Viewpoint
This contribution should be solicited by the Editors and deal with a controversial topic in either basic or clinical endocrinology on which the author, a leading expert in the field, is invited to express his views and interpretation of current literature. This type of article has a word limit of 1500, 1 figure or table and no more than 30 references.
7. Editorial
This contribution should be solicited by the Editors and relates to the topic of one or more contributions published in the same issue of the journal. This type of article has a word limit of 1500 and no more than 20 references.
8. Research Letter
This contribution contains particularly original preliminary basic or clinical data presented in a very concise way (no abstract, word limit of 1250, 1 table of figure and maximum 20 references).
9. Endocrine Genetics/Epigenetics
This contribution contains novel insights in the genetics/epigenetics in endocrine physiology and diseases. Data should be presented in a concise way (word limit of 2000, 2 table or figure and maximum 30 references.
10. Book review
This contribution should be a short evaluation from an expert in the field on a relevant book in a certain area of endocrinology. This article should not exceed 750 words and no references are allowed.
11. Letter to the Editor
Text is limited to 750 words, with no abstract. There may be 1 figure, up to 3 references, and no more than 3 authors, with author affiliations only including main institution, place name and (state plus) country (i.e. no departments, etc).
12. Endocrine Imaging
Text is limited to 500 words, with no abstract, and illustrative of 1 Figure in which a particularly significant and original result of an imaging technique (e.g. MRI, CT, ultrasound) obtained during the diagnostic process of an endocrine disease should be included. No more than 3 references and 3 authors (with author affiliations only including main institution, place name and (state plus) country) are allowed.
13. Pros and Cons in Endocrine Practice
This contribution should deal with a controversial topic in endocrine practice in which pros and cons of an endocrine disease treatment or diagnostic process are examined and reported in a balanced and constructive way. A proposed algorithm or indication for an integrated approach should be produced. This type of article has a word limit of 2000, 1 figure and 1 table, no more than 50 references and can be written by a single author reviewing the two sides of the topic or by two authors each dealing with one aspect of the topic.
14. Endocrine Methods and Techniques
This contribution contains the description of a previously unreported research method or modification of an already known method particularly relevant to the endocrine field. New laboratory assays for hormone measurement as well as new diagnostic techniques or new applications of a diagnostic technique are also eligible for this manuscript category. Data should be presented in a concise way (word limit of 1500, 1 table or figure and maximum 25 references).
15. Endocrine Trials
This contribution is devoted to registered clinical trials in which treatments for an endocrine or metabolic disease are studied. Manuscripts can deal with the description of the protocol of a trial, can report data from interim analysis of an ongoing clinical trial, can report preliminary or final results of the trial as well as post-hoc analysis of the trial. The authors are invited not to exceed 2500 words and 75 references for reporting final results of a trial. Interim analysis or preliminary data of an ongoing clinical trial as well as post-hoc analysis of a trial should not exceed 1500 words and 50 references. The authors should not exceed 1000 words and 30 references for the description of the protocol of a new trial.
16. Side Effects of Endocrine Treatments
Text is limited to 500 words, with no abstract and only one Figure if strictly necessary, with the description of a potential side effect not previously reported which occurred during the treatment with an endocrine drug or of an endocrine disease. No more than 3 references and 3 authors (with author affiliations only including main institution, place name and (state plus) country) are allowed.
17. Clinical Management of Endocrine Diseases
This contribution should discuss the practical aspects of the management of an endocrine or metabolic disease with particular reference to critical aspects of the clinical guidelines in the specific field if available. Resulting decisional diagnostic and therapeutic algorithms should be aimed at helping clinicians in their daily practice. This type of article is generally invited, has a word limit of 2000, no more than 2 figures and 75 references.
18. Position statements/Guidelines
Editors of Endocrine can appoint a panel of authoritative experts to write a position paper/guideline article on a new or controversial clinical topic based on available evidence analyzed by the Grade system. Unsolicited position statement and/or guideline papers from expert panels can be submitted to Endocrine but authors are advised to contact in advance the Editor-in-Chief (editor.endocrine@gmail.com) with an outline of the proposed article and CV of the authors. This type of article should not exceed 3000 words and 250 references.
19. Endocrine Surgery
This contribution is devoted to report original manuscripts on innovative techniques in endocrine surgery as well as on results and side effects of surgical treatment of endocrine diseases. Manuscripts should not exceed 2500 words, 100 references and 4 Figures or Tables.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide a structured abstract of 150 to 250 words which should be divided into the following sections:
Purpose (stating the main purposes and research question)
Methods
Results
Conclusion
For life science journals only (when applicable)
Trial registration number and date of registration
Trial registration number, date of registration followed by “retrospectively registered”
Keywords
Please provide 4 to 6 keywords which can be used for indexing purposes.
Declarations
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
To be used for all articles, including articles with biological applications
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
Text
Text Formatting
Manuscripts should be submitted in Word.
Use a normal, plain font (e.g., 10-point Times Roman) for text.
Use italics for emphasis.
Use the automatic page numbering function to number the pages.
Do not use field functions.
Use tab stops or other commands for indents, not the space bar.
Use the table function, not spreadsheets, to make tables.
Use the equation editor or MathType for equations.
Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
Headings
Please use no more than three levels of displayed headings.
Abbreviations
Abbreviations should be defined at first mention and used consistently thereafter.
Footnotes
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.
Acknowledgments
Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.
References
Citation
Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].
Reference list
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text.
The entries in the list should be numbered consecutively.
If available, please always include DOIs as full DOI links in your reference list (e.g. “https://doi.org/abc”).
Journal article
Hamburger, C.: Quasimonotonicity, regularity and duality for nonlinear systems of partial differential equations. Ann. Mat. Pura Appl. 169, 321–354 (1995)
Article by DOI
Sajti, C.L., Georgio, S., Khodorkovsky, V., Marine, W.: New nanohybrid materials for biophotonics. Appl. Phys. A (2007). https://doi.org/10.1007/s00339-007-4137-z
Book
Geddes, K.O., Czapor, S.R., Labahn, G.: Algorithms for Computer Algebra. Kluwer, Boston (1992)
Book chapter
Broy, M.: Software engineering — from auxiliary to key technologies. In: Broy, M., Denert, E. (eds.) Software Pioneers, pp. 10–13. Springer, Heidelberg (2002)
Online document
Cartwright, J.: Big stars have weather too. IOP Publishing PhysicsWeb. http://physicsweb.org/articles/news/11/6/16/1 (2007). Accessed 26 June 2007
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see
ISSN.org LTWA
If you are unsure, please use the full journal title.
……
